Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Impedimed Limited ( (AU:IPD) ) has provided an announcement.
ImpediMed Limited has announced a change in the director’s interest notice, specifically for Ms. Christine Emmanuel-Donnelly. The change involves the issuance of shares in lieu of 30% of director fees for the quarter ended 31 March 2025. This adjustment reflects a strategic decision to align director compensation with company performance, potentially impacting the company’s financial management and shareholder relations.
More about Impedimed Limited
ImpediMed Limited operates in the medical technology industry, focusing on the development and sale of bioimpedance spectroscopy devices. These devices are primarily used for the non-invasive assessment of fluid status and body composition, with applications in healthcare sectors such as oncology, cardiology, and renal care.
YTD Price Performance: -50.0%
Average Trading Volume: 74,308
Technical Sentiment Signal: Buy
Current Market Cap: $44M
Learn more about IPD stock on TipRanks’ Stock Analysis page.